Thymomas are tumors of the thymus and are benign in around 75% of cases. A quarter of thymomas are malignant – they are divided into malignant thymomas and thymic carcinomas depending on the appearance and degree of differentiation of the diseased cells and their tendency to spread [1,3,4]. At 0.2-1.5% of all human malignancies in German-speaking countries and 1.7/1,000,000 in Europe, they account for a very small proportion.
Autoren
- Dr. med. Hans-Joachim Thiel
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Development of a quintuple agonist
New strategy in the fight against obesity and T2D
- From symptom to diagnosis
Oncocytoma
- Arterial elasticity, vascular ageing, endothelial function
Longevity and cardiovascular health 2025
- AI-supported risk stratification for chest pain in the emergency room
Performance of a fully automated ECG model
- Alternative to insulin and GLP1
From the β-cell to the center: the versatile role of amylin
- Hormone balance and longevity
Ageing is not a substitution diagnosis
- Cardiovascular risk
Bad news for young men with T2D
- Case Report